The Impact of the RBM4-Initiated Splicing Cascade on Modulating The

Total Page:16

File Type:pdf, Size:1020Kb

The Impact of the RBM4-Initiated Splicing Cascade on Modulating The www.nature.com/scientificreports OPEN The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal Received: 11 November 2016 Accepted: 06 February 2017 cancer cells Published: 09 March 2017 Jung-Chun Lin1, Yuan-Chii Lee2,*, Yu-Chih Liang1,*, Yang C. Fann3, Kory R. Johnson3 & Ying-Ju Lin4 A growing body of studies has demonstrated that dysregulated splicing profiles constitute pivotal mechanisms for carcinogenesis. In this study, we identified discriminative splicing profiles of colorectal cancer (CRC) cells compared to adjacent normal tissues using deep RNA-sequencing (RNA-seq). The RNA-seq results and cohort studies indicated a relatively high ratio of exon 4-excluded neuro- oncological ventral antigen 1 (Nova1−4) and intron 2-retained SRSF6 (SRSF6+intron 2) transcripts in CRC tissues and cell lines. Nova1 variants exhibited differential effects on eliminating SRSF6 expression in CRC cells by inducing SRSF6+intron 2 transcripts which were considered to be the putative target of alternative splicing-coupled nonsense-mediated decay mechanism. Moreover, the splicing profile of vascular endothelial growth factor (VEGF)165/VEGF165b transcripts was relevant to SRSF6 expression, which manipulates the progression of CRC calls. These results highlight the novel and hierarchical role of an alternative splicing cascade that is involved in the development of CRC. Alternative splicing constitutes a major mechanism in expanding the proteome diversity of eukaryotic cells1. Recent studies demonstrated that more than 90% of protein-coding genes generate more than one transcript through this meticulously controlled process2. In normal tissues, spatiotemporal expression profiles of alternative splicing events determine cell differentiation and specification3, whereas imbalanced or aberrant alternative splic- ing profiles are highly relevant to hereditary diseases and cancers4,5. The interplay between splicing factors, such as serine-arginine (SR) or the heteronuclear ribonucleoprotein (hnRNP) protein family, and cis-elements within cassette exons of alternative splicing events, constitutes the molecular mechanism of programming splicing pro- files6. Altered expressions or distributions of splicing factors were subsequently noted to be an efficient means for reprogramming splicing profiles of cancer cells7,8. Statistical studies indicated that while colorectal cancer (CRC) is the third most common and lethal cancer in the human race, the etiology and molecular mechanisms leading to CRC are largely unclear9. However, several alternative splicing events are widely observed and relevant to the development of CRC10. For instance, upreg- ulation of SRSF10 expression results in an increase in BCLAF1 exon 5a-included transcripts which facilitates the progression of CRC11. In addition, an increase in the expression of polypyrimidine tract-binding protein 1 (PTBP1) leads to a relatively high level of the PKM2 variant which mediates the Warburg effect in CRC cells12. Our previous work reported that overexpression of RNA-binding motif protein 4 (RBM4) constitutes a regulatory network in reprogramming splicing profiles of the FGFR2 and PKM genes, which modulate the progression and metabolic signature of CRC cells13. With the development of high-throughput approaches, including deep RNA sequencing (RNA-seq) and RNA crosslink immunoprecipitation-coupled proteomic analyses, alternative splicing networks can be investigated on a genome-wide level14,15. In this study, we performed RNA-seq analyses to thoroughly annotate transcriptomes in 1School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. 2Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei, Taiwan. 3Information Technology and Bioinformatics Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. 4School of Chinese Medicine, China Medical University, Taichung, Taiwan. *These authors contributed equally to this work. Correspondence and requests for materials should be addressed to J.-C.L. (email: [email protected]) SCIENTIFIC REPORTS | 7:44204 | DOI: 10.1038/srep44204 1 www.nature.com/scientificreports/ Figure 1. Transcriptome and gene ontology analyses of paired colorectal cancer (CRC) tissues. (a) Statistical summaries of transcriptome analytical results. (b) Transcriptome analysis-identified splicing events significantly changed in CRC tissues compared to adjacent normal tissues. (c) The top 11 enriched functions for differentially spliced genes in CRC tissues. CRC tissues and adjacent normal tissues. Among these alternative splicing events, RBM4, Nova1, SRSF6, and vas- cular endothelial growth factor 165 (VEGF165) comprised a splicing cascade in a consensus sequence-dependent manner which manipulated the migration and angiogenetic signature of CRC cells. These results suggested the potential value of splicing events as clinical applications for CRC treatment. Results Genome-wide analyses of CRC-associated alternative splicing events. Disclosing an imbalanced or aberrant splicing event may bring about a comprehensive understanding of the genetic causes of distinct malig- nancies. We therefore performed transcriptome analyses using deep RNA-seq with total RNAs extracted from cancerous and adjacent normal tissues of anonymous CRC patients. The statistical summary of the RNA-seq out- put showed close numbers of read lengths, amplified reads, and mapping rates within the independent analyses (Fig. 1a, n =​ 6). After filtering differentially spliced transcripts with a false detection rate (FDR)-adjusted p value of <​0.01, a q value of <​0.05, and a multiple of change of >​2, 153 genes from a total of 22,518 splicing events that significantly differed in cancerous tissues compared to adjacent normal counterparts were identified. Figure 1b presents 42 genes which exhibited differential splicing profiles between CRC cancerous tissues and adjacent nor- mal tissues. For instance, the relative level of the Nova1−4 transcript was significantly upregulated in cancerous tissues (Fig. 1b, 2.2237) compared to adjacent normal tissues (Fig. 1b, 0.3417). In contrast, relative expression of the non-coding SRSF6 transcripts in cancerous tissues (Fig. 1b, 79.3127) was more abundant than that of adjacent normal tissues (Fig. 1b, 13.0158). Gene ontology (GO) analyses were next conducted by examining putative CRC- related splicing events. Figure 1c shows the analytical summary (upper) and the bar chart (lower) presents the p values of the GO analyses. Results showed the enrichment of CRC-related splicing events involved in cytoskeletal, signaling receptor, and cell adhesion terms, which are highly related to the progression of cancer cells. Moreover, enriched terms corresponding to RNA metabolism and biosynthesis also implied a potential impact of RNA- binding proteins, including Nova1 and SRSF6 genes (Fig. 1b), on the carcinogenic signature of CRC cells. Differential expressions and splicing profiles of Nova1 and SRSF6 in CRC tissues. To validate the identified results regarding the splicing profiles of Nova1 and SRSF6 genes, RT-PCR analyses were conducted with RNAs prepared from cancerous tissues and adjacent normal tissues of anonymous CRC patients (Fig. 2a, n =​ 10). Figure 2a shows the predominant expression of exon 4-excluded Nova1 transcripts (Nova1−4, 60.1%, white bar) in cancerous tissues, whereas the reduced expression of Nova1−4 transcript (12.5%, white bar) was noted in the adjacent normal tissues of CRC patients. Furthermore, results of the RT-qPCR showed elevated total Nova1 tran- scripts in cancerous tissues compared to adjacent normal tissues (by about 4.4-fold; Fig. 2a, qRT-PCR). In addi- tion to Nova1, RNA-seq results also indicated differential splicing profiles of the SRSF6 gene between normal and cancerous tissues (Fig. 1b, lower table). The RT-PCR results showed that adjacent normal tissues exhibited pre- dominant expression of authentic SRSF6 transcripts (Fig. 2a, NM_006275; 87%, black bar) encoding functional SRSF6 proteins, whereas splicing profiles of the SRSF6 gene in cancerous tissues were shifted to non-coding SRSF6 SCIENTIFIC REPORTS | 7:44204 | DOI: 10.1038/srep44204 2 www.nature.com/scientificreports/ Figure 2. Differential splicing and expression profiles of Nova1 and SRSF6 in colorectal cancer (CRC) tissues and derived cell lines. (a) Total RNAs prepared from human CRC tissues (T) and adjacent non-tumorous tissues (NT) were subjected to RT-PCR and RT-qPCR analyses with specific primer sets complementary to the Nova1 and SRSF6 transcripts. The bar graphs present relative levels of the Nova1 and SRSF6 transcripts (left) or total Nova1 transcripts (right) in paired CRC tissues (n =​ 10). (b) Total lysates prepared from human CRC tissues (T) and adjacent non-tumorous tissues (NT) were analyzed using an immunoblot assay with the indicated antibodies. The bar graph presents relative levels of Nova1 and SRSF6 proteins in paired CRC tissues (n =​ 8). (c) Total RNAs and lysates prepared from CRC-derived cell lines were analyzed by RT-PCR assays with a specific primer set against the Nova1 and SRSF6 genes. Western blotting was performed with the indicated antibodies. The bar graph presents relative levels of the Nova1+4 and SRSF6 transcripts in three independent experiments. The gels shown in this figure were run under the same conditions and were
Recommended publications
  • A Post-Transcriptional Mechanism Pacing Expression of Neural Genes with Precursor Cell Differentiation Status
    ARTICLE Received 24 Sep 2014 | Accepted 21 May 2015 | Published 6 Jul 2015 DOI: 10.1038/ncomms8576 OPEN A post-transcriptional mechanism pacing expression of neural genes with precursor cell differentiation status Weijun Dai1, Wencheng Li2, Mainul Hoque2, Zhuyun Li1, Bin Tian2 & Eugene V. Makeyev1,3 Nervous system (NS) development relies on coherent upregulation of extensive sets of genes in a precise spatiotemporal manner. How such transcriptome-wide effects are orchestrated at the molecular level remains an open question. Here we show that 30-untranslated regions (30 UTRs) of multiple neural transcripts contain AU-rich cis-elements (AREs) recognized by tristetraprolin (TTP/Zfp36), an RNA-binding protein previously implicated in regulation of mRNA stability. We further demonstrate that the efficiency of ARE-dependent mRNA degradation declines in the neural lineage because of a decrease in the TTP protein expression mediated by the NS-enriched microRNA miR-9. Importantly, TTP downregulation in this context is essential for proper neuronal differentiation. On the other hand, inactivation of TTP in non-neuronal cells leads to dramatic upregulation of multiple NS-specific genes. We conclude that the newly identified miR-9/TTP circuitry limits unscheduled accumulation of neuronal mRNAs in non-neuronal cells and ensures coordinated upregulation of these transcripts in neurons. 1 School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore. 2 Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School, Newark, New Jersey 07103, USA. 3 MRC Centre for Developmental Neurobiology, King’s College London, London SE1 1UL, UK. Correspondence and requests for materials should be addressed to E.V.M.
    [Show full text]
  • Reintroduction of the Archaic Variant of NOVA1
    RESEARCH ◥ protein-coding differences between modern RESEARCH ARTICLE SUMMARY human and archaic hominin genomes that could affect human neurodevelopment. HUMAN EVOLUTION RATIONALE: NOVA1 regulates alternative splic- Reintroduction of the archaic variant of NOVA1 in ing in the developing nervous system and is a master regulator of splicing genes responsible cortical organoids alters neurodevelopment for synapse formation. Altered NOVA1 splicing activity in humans is associated with neurolog- Cleber A. Trujillo, Edward S. Rice, Nathan K. Schaefer, Isaac A. Chaim, Emily C. Wheeler, Assael A. Madrigal, ical disorders, underscoring the role of NOVA1 in Justin Buchanan, Sebastian Preissl, Allen Wang, Priscilla D. Negraes, Ryan A. Szeto, Roberto H. Herai, neural function. Using CRISPR-Cas9 genome- Alik Huseynov, Mariana S. A. Ferraz, Fernando S. Borges, Alexandre H. Kihara, Ashley Byrne, editing technology in human induced pluripo- Maximillian Marin, Christopher Vollmers, Angela N. Brooks, Jonathan D. Lautz, Katerina Semendeferi, tent stem cells (iPSCs), we replaced the modern Beth Shapiro, Gene W. Yeo, Stephen E. P. Smith, Richard E. Green, Alysson R. Muotri* human allele of the NOVA1 gene with the ancestral allele found in Neanderthals and Denisovans, which contains a single-nucleotide INTRODUCTION: Current views of human evo- cies. Comparison of Neanderthal, Denisovan, substitution at position 200 that causes an lution, as supported by the fossil record, in- and extant human genomes has shown that isoleucine-to-valine change. To investigate the dicate that many hominin lineage branches many humans today carry genes introduced functional importance of this amino acid change arose, but only one survived to the present. through past admixture events and has allowed in humans, we followed iPSC neural develop- Downloaded from Neanderthals and Denisovans, two of these enumeration of human-specific genetic differ- ment through functional cortical organoids.
    [Show full text]
  • New Clinical Insights and Physical Mapping of FOXG1-Regulatory Elements
    European Journal of Human Genetics (2012) 20, 1216–1223 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg ARTICLE 14q12 and severe Rett-like phenotypes: new clinical insights and physical mapping of FOXG1-regulatory elements Lila Allou1,15, Laetitia Lambert1,2,3,15, Daniel Amsallem4, Eric Bieth5, Patrick Edery6,7, Anne Destre´e8, Franc¸ois Rivier9,DavidAmor10, Elizabeth Thompson11, Julian Nicholl12, Michael Harbord13,ChristopheNemos1, Aline Saunier14, Aissa Moustaı¨ne14, Adeline Vigouroux5, Philippe Jonveaux1,14 and Christophe Philippe*,1,14 The Forkhead box G1 (FOXG1) gene has been implicated in severe Rett-like phenotypes. It encodes the Forkhead box protein G1, a winged-helix transcriptional repressor critical for forebrain development. Recently, the core FOXG1 syndrome was defined as postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and dysgenesis of the corpus callosum. We present seven additional patients with a severe Rett-like neurodevelopment disorder associated with de novo FOXG1 point mutations (two cases) or 14q12 deletions (five cases). We expand the mutational spectrum in patients with FOXG1-related encephalopathies and precise the core FOXG1 syndrome phenotype. Dysgenesis of the corpus callosum and dyskinesia are not always present in FOXG1-mutated patients. We believe that the FOXG1 gene should be considered in severely mentally retarded patients (no speech-language) with severe acquired microcephaly ( À4toÀ6 SD) and few clinical features suggestive of Rett syndrome. Interestingly enough, three 14q12 deletions that do not include the FOXG1 gene are associated with phenotypes very reminiscent to that of FOXG1-mutation-positive patients. We physically mapped a putative long-range FOXG1-regulatory element in a 0.43 Mb DNA segment encompassing the PRKD1 locus.
    [Show full text]
  • 1 Complexity and Graded Regulation of Neuronal Cell Type-Specific
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.27.428525; this version posted January 28, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Complexity and graded regulation of neuronal cell type-specific alternative splicing revealed by single-cell RNA sequencing Huijuan Feng1, Daniel F. Moakley1, Shuonan Chen1, Melissa G. McKenzie1, Vilas Menon2, Chaolin Zhang1 1Department of Systems Biology, Department of Biochemistry and Molecular Biophysics, Center for Motor Neuron Biology and Disease, Columbia University, New York NY 10032, USA 2 Department of Neurology, Taub Institute for Research on Alzheimer Disease and the Aging Brain, Columbia University, New York NY 10032, USA *To whom correspondence should be addressed: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.27.428525; this version posted January 28, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract The enormous neuronal cellular diversity in the mammalian brain, which is highly prototypical and organized in a hierarchical manner, is dictated by cell type-specific gene regulatory programs at the molecular level. Although prevalent in the brain, contribution of alternative splicing (AS) to the molecular diversity across neuronal cell types is just starting to emerge.
    [Show full text]
  • Enriched Alternative Splicing in Islets of Diabetes-Susceptible Mice
    International Journal of Molecular Sciences Article Enriched Alternative Splicing in Islets of Diabetes-Susceptible Mice Ilka Wilhelmi 1,2, Alexander Neumann 3 , Markus Jähnert 1,2 , Meriem Ouni 1,2,† and Annette Schürmann 1,2,4,5,*,† 1 Department of Experimental Diabetology, German Institute of Human Nutrition (DIfE), 14558 Potsdam, Germany; [email protected] (I.W.); [email protected] (M.J.); [email protected] (M.O.) 2 German Center for Diabetes Research (DZD), 85764 Munich, Germany 3 Omiqa Bioinformatics, 14195 Berlin, Germany; [email protected] 4 Institute of Nutritional Sciences, University of Potsdam, 14558 Nuthetal, Germany 5 Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology Cottbus-Senftenberg, The Brandenburg Medical School Theodor Fontane and The University of Potsdam, 14469 Potsdam, Germany * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Dysfunctional islets of Langerhans are a hallmark of type 2 diabetes (T2D). We hypoth- esize that differences in islet gene expression alternative splicing which can contribute to altered protein function also participate in islet dysfunction. RNA sequencing (RNAseq) data from islets of obese diabetes-resistant and diabetes-susceptible mice were analyzed for alternative splicing and its putative genetic and epigenetic modulators. We focused on the expression levels of chromatin modifiers and SNPs in regulatory sequences. We identified alternative splicing events in islets of diabetes-susceptible mice amongst others in genes linked to insulin secretion, endocytosis or Citation: Wilhelmi, I.; Neumann, A.; ubiquitin-mediated proteolysis pathways. The expression pattern of 54 histones and chromatin Jähnert, M.; Ouni, M.; Schürmann, A.
    [Show full text]
  • In Vitro and in Silico Analysis of Mir-125A with Rs12976445 Polymorphism in Breast Cancer Patients
    applied sciences Article In Vitro and in Silico Analysis of miR-125a with rs12976445 Polymorphism in Breast Cancer Patients Tomasz P. Lehmann 1,* , Joanna Miskiewicz 2, Natalia Szostak 3 , Marta Szachniuk 2,3,*, Sylwia Grodecka-Gazdecka 4 and Paweł P. Jagodzi ´nski 1 1 Department of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Swiecickiego 6, 60-781 Poznan, Poland; [email protected] 2 Institute of Computing Science, Poznan University of Technology, Piotrowo 2, 60-965 Poznan, Poland; [email protected] 3 Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland; [email protected] 4 Department of Surgery, Chair and Clinic of Oncology Poznan University of Medical Sciences, Szamarzewskiego 82/84, 61-001 Poznan, Poland; [email protected] * Correspondence: [email protected] (T.P.L.); [email protected] (M.S.); Tel.: +48-618-546-513 (T.P.L.); +48-616-653-030 (M.S.); Fax: +48-854-6510 (T.P.L.); +48-618-771-525 (M.S.) Received: 23 September 2020; Accepted: 15 October 2020; Published: 17 October 2020 Abstract: Background: Breast cancer affects over 2 million women yearly. Its early detection allows for successful treatment, which motivates to research factors that enable an accurate diagnosis. miR-125a is one of them, correlating with different types of cancer. For example, the miR-125a level decreases in breast cancer tissues; polymorphisms in the miR-125a encoding gene are related to prostate cancer and the risk of radiotherapy-induced pneumonitis. Methods: In this work, we investigated two variants of rs12976445 polymorphism in the context of breast cancer.
    [Show full text]
  • Identification of Core Genes Involved in the Progression of Cervical
    International Journal of Molecular Sciences Article Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis Marina Dudea-Simon 1, Dan Mihu 1, Alexandru Irimie 2,3, Roxana Cojocneanu 4, Schuyler S. Korban 5, Radu Oprean 6, Cornelia Braicu 4,* and Ioana Berindan-Neagoe 4,7 1 2nd Obstetrics and Gynecology Department, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania; [email protected] (M.D.-S.); [email protected] (D.M.) 2 Department of Surgery, “Prof. Dr. Ion Chiricuta” Oncology Institute, 400015 Cluj-Napoca, Romania; [email protected] 3 Department of Surgical Oncology and Gynecological Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 4 Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 23 Marinescu Street, 400337 Cluj-Napoca, Romania; [email protected] (R.C.); [email protected] (I.B.-N.) 5 Department of Natural and Environmental Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA; [email protected] 6 Analytical Chemistry Department, Iuliu Hatieganu University of Medicine and Pharmacy, 4, Louis Pasteur Street, 400349 Cluj-Napoca, Romania; [email protected] 7 Department of Functional Genomics and Experimental Pathology, “Prof. Dr. Ion Chiricu¸tă” Oncology Institute, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania * Correspondence: [email protected] Received: 5 September 2020; Accepted: 1 October 2020; Published: 3 October 2020 Abstract: In spite of being a preventable disease, cervical cancer (CC) remains at high incidence, and it has a significant mortality rate. Although hijacking of the host cellular pathway is fundamental for developing a better understanding of the human papillomavirus (HPV) pathogenesis, a major obstacle is identifying the central molecular targets involved in HPV-driven CC.
    [Show full text]
  • NOVA1 Promotes SMN2 Exon 7 Splicing Via Binding the UCAC Motif and Increases SMN Protein Expression
    NOVA1 Promotes SMN2 Exon 7 Splicing via Binding the UCAC Motif and Increases SMN Protein Expression Lili Du Nantong University Junjie Sun Nantong University Zhiheng Chen Nantong University Yixiang Shao Nantong University Liucheng Wu ( [email protected] ) Nantong University https://orcid.org/0000-0002-8053-1340 Research Article Keywords: spinal muscular atrophy, motor neuron, NOVA1, YCAY motif, SMN2 splicing Posted Date: August 12th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-798194/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/24 Abstract Spinal muscular atrophy (SMA) is a rare hereditary neuromuscular disease with high lethality rate in infants. Homologous genes SMN1 and SMN2 were reported to be SMA pathogenic factors. Studies showed that high inclusion of SMN2 exon 7 increased SMN expression which in turn ameliorated the severity of SMA. The inclusion rate of SMN2 exon 7 was higher in neural tissues than that in non-neural tissues. Expression of splicing factors that regulate inclusion of SMN2 exon 7 were signicantly increased in neural tissues compared to non-neural ones. A positive correlation was checked between expression of neuro-oncological ventral antigen 1(NOVA1) and SMN in central nervous system. In addition, reduced number of neurons in the spinal cord anterior horn was determined by Nissl staining in SMA mice from postnatal day 1 to 7 continuously. Meanwhile, NOVA1 was presented in motor neurons and gradually decreased as SMA ongoing. Moreover, SMN2 exon 7 inclusion and protein level were enhanced by overexpressing NOVA1, while the enhancement was reversed when NOVA1 knockdown in vitro.
    [Show full text]
  • Endothelial, Epithelial, and Fibroblast Cells Exhibit Specific Splicing Programs Independently of Their Tissue of Origin
    Downloaded from genome.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin Pierre Mallinjoud1-4,§, Jean-PhilippeVillemin1-4,§, Hussein Mortada1-4,§, Micaela Polay- Espinoza1-4, François-Olivier Desmet1-4, Samaan Samaan1-4, Emilie Chautard1-4, Léon-Charles Tranchevent1-4, Didier Auboeuf1-4,* 1) Inserm UMR-S1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France, 2) CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France, 3) Université de Lyon, Lyon, France, 4) Centre Léon Bérard, Lyon, France, (§)These authors contributed equally to this work. * To whom correspondence should be addressed: Didier Auboeuf, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, 28 Rue Laënnec, 69008 Lyon, France. Phone: (+33) 4 26 55 67 46. E-mail: [email protected] Running title: Cell type-specific splicing programs Keywords: Alternative splicing; database; transcriptomics; splicing programs; splicing factors 1 Downloaded from genome.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Alternative splicing is the main mechanism of increasing the proteome diversity coded by a limited number of genes. It is well established that different tissues or organs express different splicing variants. However, organs are composed of common major cell types, including fibroblasts, epithelial, and endothelial cells. By analyzing large-scale datasets
    [Show full text]
  • NOVA2-Mediated RNA Regulation Is Required for Axonal Pathfinding
    RESEARCH ARTICLE NOVA2-mediated RNA regulation is required for axonal pathfinding during development Yuhki Saito1, Soledad Miranda-Rottmann1†‡, Matteo Ruggiu1†§, Christopher Y Park2, John J Fak1, Ru Zhong1, Jeremy S Duncan3¶, Brian A Fabella4, Harald J Junge5, Zhe Chen5, Roberto Araya6‡, Bernd Fritzsch3, A J Hudspeth4, Robert B Darnell1,2* 1Laboratory of Molecular Neuro-Oncology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States; 2New York Genome Center, New York, United States; 3Department of Biology, College of Liberal Arts and Sciences, University of Iowa, Iowa City, United States; 4Laboratory of Sensory Neuroscience, Howard Hughes Medical Institute, The Rockefeller University, New York, United States; 5Department of Molecular, Cellular, and Developmental Biology, University 6 *For correspondence: darnelr@ of Colorado, Boulder, Boulder, United States; Department of Neurosciences, rockefeller.edu Faculty of Medicine, University of Montreal, Montreal, Canada †These authors contributed equally to this work Present address: ‡Department Abstract The neuron specific RNA-binding proteins NOVA1 and NOVA2 are highly homologous of Neurosciences, Faculty of alternative splicing regulators. NOVA proteins regulate at least 700 alternative splicing events in Medicine, University of Montreal, vivo, yet relatively little is known about the biologic consequences of NOVA action and in particular § Montreal, Canada; Department about functional differences between NOVA1 and NOVA2. Transcriptome-wide searches for of Biological Sciences, St. John’s isoform-specific functions, using NOVA1 and NOVA2 specific HITS-CLIP and RNA-seq data from University, Utopia Parkway, mouse cortex lacking either NOVA isoform, reveals that NOVA2 uniquely regulates alternative United States; ¶Division of splicing events of a series of axon guidance related genes during cortical development.
    [Show full text]
  • Position Effect Leading to Haploinsufficiency in a Mosaic Ring Chromosome 14 in a Boy with Autism
    European Journal of Human Genetics (2008) 16, 1187–1192 & 2008 Macmillan Publishers Limited All rights reserved 1018-4813/08 $32.00 www.nature.com/ejhg ARTICLE Position effect leading to haploinsufficiency in a mosaic ring chromosome 14 in a boy with autism Dries Castermans1, Bernard Thienpont2, Karolien Volders1, An Crepel2, Joris R Vermeesch2, Connie T Schrander-Stumpel3, Wim JM Van de Ven4, Jean G Steyaert2,3,5, John WM Creemers1 and Koen Devriendt*,2 1Department for Human Genetics, Laboratory for Biochemical Neuroendocrinology, University of Leuven, Belgium; 2Division of Clinical Genetics, Center for Human Genetics, University of Leuven, Belgium; 3Department of Clinical Genetics, Academic Hospital Maastricht, Research Institute Growth and Development (GROW), Maastricht University, The Netherlands; 4Department for Human Genetics, Laboratory for Molecular Oncology, University of Leuven, Belgium; 5Department of Child Psychiatry, University of Leuven, Belgium We describe an individual with autism and a coloboma of the eye carrying a mosaicism for a ring chromosome consisting of an inverted duplication of proximal chromosome 14. Of interest, the ring formation was associated with silencing of the amisyn gene present in two copies on the ring chromosome and located at 300 kb from the breakpoint. This observation lends further support for a locus for autism on proximal chromosome 14. Moreover, this case suggests that position effects need to be taken into account, when analyzing genotype–phenotype correlations based on chromosomal imbalances. European Journal of Human Genetics (2008) 16, 1187–1192; doi:10.1038/ejhg.2008.71; published online 16 April 2008 Keywords: autism; mosaic ring chromosome 14; position effect; amisyn Introduction in a mosaic state.
    [Show full text]
  • Nova Proteins Direct Synaptic Integration of Somatostatin Interneurons Through Activity- Dependent Alternative Splicing
    bioRxiv preprint doi: https://doi.org/10.1101/845230; this version posted November 16, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Nova proteins direct synaptic integration of somatostatin interneurons through activity- dependent alternative splicing Brie Wamsley1,3,7+, Leena A. Ibrahim3,4,7, Nusrath Yusuf1,3,4, Elaine Fisher3,4, Xavier Hubert Jaglin1,3, Qing Xu5, Lihua Guo5, Alireza Khodadadi-Jamayran2, Emilia Favuzzi3,4, Yuan Yuan6, Jordane 4 6 1,3,4,# Dimidschstein , Robert Darnell , and Gord Fishell 1 NYU Neuroscience Institute and the Department of Neuroscience and Physiology; Smilow Research Center, New York University School of Medicine, 522 First Avenue; New York, NY 10016, USA. 2 Genome Technology Center, Applied Bioinformatics Laboratories, NYU Langone Medical Center; 550 First Avenue, MSB 304; New York, NY 10016, USA. 3Department of Neurobiology, Harvard Medical School, 220 Longwood Ave., Boston, MA 02115 4Stanley Center at the Broad, 75 Ames St., Cambridge, MA 02142 5Center for Genomics & Systems Biology, New York University, Abu Dhabi, UAE 6Laboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, NY 7 These authors contributed equally +Current address: Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA # Lead and corresponding author: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/845230; this version posted November 16, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]